| abstract |
The present invention relates to the use of a shark cartilage extract for the manufacture of a medicament for the treatment of diseases or disorders having a collagenolytic or inflammatory component, provided that the disease or disorder is not cancer, psoriasis, acne or arthritis, wherein said shark cartilage extract is obtainable after centrifuging the aqueous solid shark cartilage homogenate, wherein said supernatant is fractionated on a filter column having a porosity of about 500,000, said extract containing molecules having a molecular weight of less than about 500,000, wherein the extract has anti-collagenolytic and anti-inflammatory activity. |